Developed by Johnson & Johnson, guselkumab is the first approved fully-human, dual-acting IL-23p19 subunit inhibitor that blocks IL-23 and binds to CD64, a receptor on cells that produce IL-23.4,12,13 ...

K92 Mining ( ($TSE:KNT) ) has issued an update. K92 Mining Inc. has responded to legal claims made by South Pacific Metals Corp. and its ...

The Canadian Digital Regulators Forum reached a major milestone in its second year of collaboration with the release of a paper exploring the impact ...

Rep. Val Hoyle is the latest member of Congress to violate a conflicts-of-interest and financial transparency law.

VANCOUVER, BC / ACCESS Newswire / September 18, 2025 / Aeonian Resources Ltd. ("Aeonian" or the "Company") is pleased to announce it has signed an ...

Carney and Sheinbaum swap notes in Mexico City. → JAMIL JIVANI on political energy after CHARLIE KIRK‘s assassination. → ...

Details of the offering can be found here Reg A+ Offering VANCOUVER, BC, Sept. /CNW/ – Damon Inc. (OTCID: DMNIF) (“Damon” or the “Company”), a designer and developer of electric ...

Arch acquires a new CKD platform that has the potential to produce next-generation CKD drugs for the pharmaceutical industryBased on a novel ...

The second-term representative was weeks or months late disclosing 217 individual stock trades, according to an OpenSecrets ...

State health officials are grappling with the stack of new regulations passed by Congressional Republicans earlier this year.

DeFi Technologies invests in Continental Stablecoin Inc.: The Company has made an investment through a SAFE to support the ...

Gold Fund A Shares (without sales charge) posted a return of 11.51% in the second quarter of 2025. Read more here.